Medifast Profit Margin

The latest profit margin for MED is -5.78% as of March 2026. That compares with -1.29% in the prior-year period — down 349.3% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Medifast's historical trend and sector peers before judging valuation or financial health.

Over the past year, MED's profit margin moved from -1.29% to -5.78% — a 349.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Medifast's valuation or profitability profile.

Against Healthcare companies, MED currently prints -5.78% for profit margin, while the sector average sits near 15.58%. That is roughly 137.1% below the sector mean. Large gaps often invite a closer look at Medifast's growth, margins, and balance sheet.

Profit Margin shows how effectively Medifast converts resources into returns. At -5.78%, MED may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.29% in the prior-year period — down 349.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MED's profit margin (-5.78%), review year-over-year change from -1.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.